Abiopharma

New Form SCHEDULE 13G/A - Quantum Biopharma Ltd. Filed: 2025-06-30 AccNo: 0002072045-25-000006 Size: 7 KB

New Form 424B5 - Ontrak, Inc. Filed: 2025-06-30 AccNo: 0001628280-25-033417 Size: 512 KB

New Form SCHEDULE 13G - Candel Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001636587-25-000035 Size: 12 KB

New Form 4 - Cardiff Oncology, Inc. Filed: 2025-06-30 AccNo: 0001641172-25-017072 Size: 5 KB

New Form 4 - Cardiff Oncology, Inc. Filed: 2025-06-30 AccNo: 0001641172-25-017071 Size: 5 KB

New Form 4 - Cardiff Oncology, Inc. Filed: 2025-06-30 AccNo: 0001641172-25-017070 Size: 5 KB

General Announcement: MONTHLY UPDATE PURSUANT TO CATALIST RULE 704(22)

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-06-30 AccNo: 0001575872-25-000428 Size: 9 MB

Aclaris Therapeutics Added to the Russell2000® and Russell 3000® Indexes

Completion of Share Buy-back Program

New Form 424B3 - Autolus Therapeutics plc Filed: 2025-06-30 AccNo: 0001730463-25-000050 Size: 131 KB

New Form 8-K - Unicycive Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059303 Size: 231 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Senti Bio Participates in Nasdaq Amplify Spotlight Series

New Form 424B5 - Inmune Bio, Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059298 Size: 242 KB

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder